News
An innovator in developing therapeutic antibodies, fusion proteins and circRNA
News
2026-06-22
Fapon Biopharma and MOTE Therapeutics Showcase Dual-Platform B-Cell Immunotherapy Franchise at BIO 2026
Read more 
2023-10-18
Fapon Shares its Visionary Strategies at the Inaugural Innovative Diagnostics and Therapeutics Forum
Fapon, a leading life sciences company, announced its strategic plans in innovative diagnostics and therapeutics business at the inaugural Innovative Diagnostics and Therapeutics Forum in Suzhou, China, on 18 October 2023.
Read more 
2023-02-22
Fapon Biopharma’s Anti-CD47 Antibody FP002 Earns IND Approval from FDA
(Feb. 22, 2023, Shenzhen, China) Fapon Biopharma, an innovative biotech company, announced today that its Investigational New Drug (IND) application of FP002.
Read more
